222 related articles for article (PubMed ID: 9100004)
1. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
Jansson M; Uhlen M; Nilsson B
Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
[TBL] [Abstract][Full Text] [Related]
2. Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro.
Hober S; Uhlén M; Nilsson B
Biochemistry; 1997 Apr; 36(15):4616-22. PubMed ID: 9109671
[TBL] [Abstract][Full Text] [Related]
3. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3.
Dubaquié Y; Lowman HB
Biochemistry; 1999 May; 38(20):6386-96. PubMed ID: 10350456
[TBL] [Abstract][Full Text] [Related]
4. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
Kolychev AP
Zh Evol Biokhim Fiziol; 2010; 46(1):74-94. PubMed ID: 20297673
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
6. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
[TBL] [Abstract][Full Text] [Related]
7. Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions.
Lowman HB; Chen YM; Skelton NJ; Mortensen DL; Tomlinson EE; Sadick MD; Robinson IC; Clark RG
Biochemistry; 1998 Jun; 37(25):8870-8. PubMed ID: 9636028
[TBL] [Abstract][Full Text] [Related]
8. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I.
Schaffer ML; Deshayes K; Nakamura G; Sidhu S; Skelton NJ
Biochemistry; 2003 Aug; 42(31):9324-34. PubMed ID: 12899619
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
Kibbey MM; Jameson MJ; Eaton EM; Rosenzweig SA
Mol Pharmacol; 2006 Mar; 69(3):833-45. PubMed ID: 16306230
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.
Siwanowicz I; Popowicz GM; Wisniewska M; Huber R; Kuenkele KP; Lang K; Engh RA; Holak TA
Structure; 2005 Jan; 13(1):155-67. PubMed ID: 15642270
[TBL] [Abstract][Full Text] [Related]
11. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance.
Carrick FE; Hinds MG; McNeil KA; Wallace JC; Forbes BE; Norton RS
J Mol Endocrinol; 2005 Jun; 34(3):685-98. PubMed ID: 15956340
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of binding staphylococcal protein A to immunoglobin G does not involve helix unwinding.
Jendeberg L; Tashiro M; Tejero R; Lyons BA; Uhlén M; Montelione GT; Nilsson B
Biochemistry; 1996 Jan; 35(1):22-31. PubMed ID: 8555177
[TBL] [Abstract][Full Text] [Related]
13. Binding affinities of insulin-like growth factor-I (IGF-I) fusion proteins to IGF binding protein 1 and IGF-I receptor are not correlated with mitogenic activity.
Jansson M; Dixelius J; Uhlen M; Nilsson BO
FEBS Lett; 1997 Oct; 416(3):259-64. PubMed ID: 9373165
[TBL] [Abstract][Full Text] [Related]
14. Model for the complex between the insulin-like growth factor I and its receptor: towards designing antagonists for the IGF-1 receptor.
Epa VC; Ward CW
Protein Eng Des Sel; 2006 Aug; 19(8):377-84. PubMed ID: 16772308
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
16. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis.
Jansson M; Andersson G; Uhlén M; Nilsson B; Kördel J
J Biol Chem; 1998 Sep; 273(38):24701-7. PubMed ID: 9733769
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
20. Involvement of phenylalanine 23 in the binding of IGF-1 to the insulin and type I IGF receptor.
Hodgson DR; May FE; Westley BR
Regul Pept; 1996 Oct; 66(3):191-6. PubMed ID: 8916274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
